WeRide Inc. (Stock Code: 0800) has issued a notice of an Extraordinary General Meeting (EGM) scheduled for March 13, 2026, at 11:00 a.m. (Beijing time), to be held at 16/F, Tower A, KWG Flourishing Biotech Square, 68 Luoxuan Boulevard, Guangzhou International Biotech Island, Huangpu District, Guangzhou, Guangdong Province, PRC.

The company set February 9, 2026 (Hong Kong time), as the record date for Class A Ordinary Shares and Class B Ordinary Shares. Holders of shares as of this date are entitled to attend and vote at the EGM. The same date (New York time) applies to holders of ADSs, who must provide voting instructions to the depositary or their intermediaries if they wish to exercise their voting rights.

Eight resolutions will be considered at the EGM. These include: proposed amendments and restatements to the Memorandum and Articles of Association (subject to conditions on class-based resolutions), granting a general unconditional mandate for the directors to allot and issue Class A Ordinary Shares, and authorizing repurchases of up to 10% of the issued shares. An extension of the issuance mandate based on repurchased shares is also under consideration. Furthermore, the meeting will decide on the proposed 2026 Share Plan, along with specific limits for overall issuances and a separate sub-limit for consultant allocations.

All shareholders who wish to attend in person must be listed on WeRide’s register of members as of February 9, 2026, and are reminded to lodge valid transfer documents before the stated deadlines. Proxy forms for shareholders must be submitted to the company’s Hong Kong share registrar 48 hours before the EGM, while ADS holders need to convey their voting instructions to the depositary by March 4, 2026 (New York time). The meeting agenda includes procedures for filings and any necessary administrative steps arising from the proposed amendments.